Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Pancreatic cancer clusters and arsenic-contaminated drinking water wells in Florida

Authors: Wen Liu-Mares, Jill A MacKinnon, Recinda Sherman, Lora E Fleming, Caio Rocha-Lima, Jennifer J Hu, David J Lee

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

We sought to identify high-risk areas of pancreatic cancer incidence, and determine if clusters of persons diagnosed with pancreatic cancer were more likely to be located near arsenic-contaminated drinking water wells.

Methods

A total of 5,707 arsenic samples were collected from December 2000 to May 2008 by the Florida Department of Health, representing more than 5,000 individual privately owned wells. During that period, 0.010 ppm (10 ppb) or greater arsenic levels in private well water were considered as the threshold based on standard of United States Environmental Protection Agency (EPA). Spatial modeling was applied to pancreatic cancer cases diagnosed between 1998–2002 in Florida (n = 11,405). Multivariable logistic regression was used to determine if sociodemographic indicators, smoking history, and proximity to arsenic-contaminated well sites were associated with residence at the time of pancreatic cancer diagnosis occurring within versus outside a cluster.

Results

Spatial modeling identified 16 clusters in which 22.6% of all pancreatic cancer cases were located. Cases living within 1 mile of known arsenic-contaminated wells were significantly more likely to be diagnosed within a cluster of pancreatic cancers relative to cases living more than 3 miles from known sites (odds ratio = 2.1 [95% CI = 1.9, 2.4]).

Conclusions

Exposure to arsenic-contaminated drinking water wells may be associated with an increased risk of pancreatic cancer. However, case–control studies are needed in order to confirm the findings of this ecological analysis. These cluster areas may be appropriate to evaluate pancreatic cancer risk factors, and to perform targeted screening and prevention studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Siegel R, Xu J, Ward E: Cancer statistics. CA Cancer J Clin. 2010, 60: 277-300. 10.3322/caac.20073.CrossRefPubMed Jemal A, Siegel R, Xu J, Ward E: Cancer statistics. CA Cancer J Clin. 2010, 60: 277-300. 10.3322/caac.20073.CrossRefPubMed
2.
go back to reference Hart AR, Kennedy H, Harvey I: Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol. 2008, 6: 275-282. 10.1016/j.cgh.2007.12.041.CrossRefPubMed Hart AR, Kennedy H, Harvey I: Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol. 2008, 6: 275-282. 10.1016/j.cgh.2007.12.041.CrossRefPubMed
3.
go back to reference Li D, Xie K, Wolff R, Abbruzzese JL: Pancreatic cancer. Lancet. 2004, 363 (9414): 1049-1057. 10.1016/S0140-6736(04)15841-8.CrossRefPubMed Li D, Xie K, Wolff R, Abbruzzese JL: Pancreatic cancer. Lancet. 2004, 363 (9414): 1049-1057. 10.1016/S0140-6736(04)15841-8.CrossRefPubMed
4.
go back to reference Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC, Michaud DS, Severinsen MT, Overvad K, Olsen A, Tjønneland A, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Rohrmann S, Boeing H, Nöthlings U, Trichopoulou A, Moutsiou E, Dilis V, Palli D, Krogh V, Panico S, Tumino R, Vineis P, van Gils CH, Peeters PH, Lund E, Gram IT, Rodríguez L, Agudo A, Larrañaga N, Sánchez MJ, Navarro C, Barricarte A, Manjer J, Lindkvist B, Sund M, Ye W, Bingham S, Khaw KT, Roddam A, Key T, Boffetta P, Duell EJ, Jenab M, Gallo V, Riboli E: Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010, 126: 2394-2403.PubMed Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC, Michaud DS, Severinsen MT, Overvad K, Olsen A, Tjønneland A, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Rohrmann S, Boeing H, Nöthlings U, Trichopoulou A, Moutsiou E, Dilis V, Palli D, Krogh V, Panico S, Tumino R, Vineis P, van Gils CH, Peeters PH, Lund E, Gram IT, Rodríguez L, Agudo A, Larrañaga N, Sánchez MJ, Navarro C, Barricarte A, Manjer J, Lindkvist B, Sund M, Ye W, Bingham S, Khaw KT, Roddam A, Key T, Boffetta P, Duell EJ, Jenab M, Gallo V, Riboli E: Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010, 126: 2394-2403.PubMed
5.
go back to reference Talamini R, Polesel J, Gallus S, Dal Maso L, Zucchetto A, Negri E, Bosetti C, Lucenteforte E, Boz G, Franceschi S, Serraino D, La Vecchia C: Tobacco smoking, alcohol consumption and pancreatic cancer risk: a case–control study in Italy. Eur J Cancer. 2010, 46: 370-376. 10.1016/j.ejca.2009.09.002.CrossRefPubMed Talamini R, Polesel J, Gallus S, Dal Maso L, Zucchetto A, Negri E, Bosetti C, Lucenteforte E, Boz G, Franceschi S, Serraino D, La Vecchia C: Tobacco smoking, alcohol consumption and pancreatic cancer risk: a case–control study in Italy. Eur J Cancer. 2010, 46: 370-376. 10.1016/j.ejca.2009.09.002.CrossRefPubMed
6.
go back to reference Stevens RJ, Roddam AW, Spencer EA, Pirie KL, Reeves GK, Green J, Beral V, Million Women Study Collaborators: Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer. 2009, 124: 2400-2405. 10.1002/ijc.24196.CrossRefPubMed Stevens RJ, Roddam AW, Spencer EA, Pirie KL, Reeves GK, Green J, Beral V, Million Women Study Collaborators: Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer. 2009, 124: 2400-2405. 10.1002/ijc.24196.CrossRefPubMed
7.
go back to reference Johansen D, Borgström A, Lindkvist B, Manjer J: Different markers of alcohol consumption, smoking and body mass index in relation to risk of pancreatic cancer. A prospective cohort study within the Malmö Preventive Project. Pancreatology. 2009, 9: 677-686. 10.1159/000212088.CrossRefPubMed Johansen D, Borgström A, Lindkvist B, Manjer J: Different markers of alcohol consumption, smoking and body mass index in relation to risk of pancreatic cancer. A prospective cohort study within the Malmö Preventive Project. Pancreatology. 2009, 9: 677-686. 10.1159/000212088.CrossRefPubMed
8.
go back to reference Arnold LD, Patel AV, Yan Y, Jacobs EJ, Thun MJ, Calle EE, Colditz GA: Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?. Cancer Epidemiol Biomarkers Prev. 2009, 18: 2397-2405. 10.1158/1055-9965.EPI-09-0080.CrossRefPubMedPubMedCentral Arnold LD, Patel AV, Yan Y, Jacobs EJ, Thun MJ, Calle EE, Colditz GA: Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?. Cancer Epidemiol Biomarkers Prev. 2009, 18: 2397-2405. 10.1158/1055-9965.EPI-09-0080.CrossRefPubMedPubMedCentral
9.
go back to reference Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL: Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009, 301: 2553-2562. 10.1001/jama.2009.886.CrossRefPubMedPubMedCentral Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL: Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009, 301: 2553-2562. 10.1001/jama.2009.886.CrossRefPubMedPubMedCentral
10.
go back to reference de Martel C, Llosa AE, Friedman GD, Vogelman JH, Orentreich N, Stolzenberg-Solomon RZ, Parsonnet J: Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1188-1194. 10.1158/1055-9965.EPI-08-0185.CrossRefPubMed de Martel C, Llosa AE, Friedman GD, Vogelman JH, Orentreich N, Stolzenberg-Solomon RZ, Parsonnet J: Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1188-1194. 10.1158/1055-9965.EPI-08-0185.CrossRefPubMed
11.
go back to reference Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D: Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case–control study. Cancer. 2007, 109: 2547-2556. 10.1002/cncr.22724.CrossRefPubMedPubMedCentral Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D: Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case–control study. Cancer. 2007, 109: 2547-2556. 10.1002/cncr.22724.CrossRefPubMedPubMedCentral
12.
go back to reference Lo AC, Soliman AS, El-Ghawalby N, Abdel-Wahab M, Fathy O, Khaled HM, Omar S, Hamilton SR, Greenson JK, Abbruzzese JL: Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas. 2007, 35: 120-129. 10.1097/mpa.0b013e318053e7d3.CrossRefPubMed Lo AC, Soliman AS, El-Ghawalby N, Abdel-Wahab M, Fathy O, Khaled HM, Omar S, Hamilton SR, Greenson JK, Abbruzzese JL: Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas. 2007, 35: 120-129. 10.1097/mpa.0b013e318053e7d3.CrossRefPubMed
13.
go back to reference Nöthlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN: Vegetable intake and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol. 2007, 165: 138-147.CrossRefPubMed Nöthlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN: Vegetable intake and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol. 2007, 165: 138-147.CrossRefPubMed
14.
go back to reference Bonelli L, Aste H, Bovo P, Cavallini G, Felder M, Gusmaroli R, Morandini E, Ravelli P, Briglia R, Lombardo L, De Micheli A, Pugliese V: Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case–control study in northern Italy. Pancreas. 2003, 27: 143-149. 10.1097/00006676-200308000-00007.CrossRefPubMed Bonelli L, Aste H, Bovo P, Cavallini G, Felder M, Gusmaroli R, Morandini E, Ravelli P, Briglia R, Lombardo L, De Micheli A, Pugliese V: Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case–control study in northern Italy. Pancreas. 2003, 27: 143-149. 10.1097/00006676-200308000-00007.CrossRefPubMed
15.
go back to reference Nilsen TI, Vatten LJ: A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trøndelag, Norway. Cancer Causes Control. 2000, 11: 645-652. 10.1023/A:1008916123357.CrossRefPubMed Nilsen TI, Vatten LJ: A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trøndelag, Norway. Cancer Causes Control. 2000, 11: 645-652. 10.1023/A:1008916123357.CrossRefPubMed
16.
go back to reference Ostrowski SR, Wilbur S, Chou CH, Pohl HR, Stevens YW, Allred PM, Roney N, Fay M, Tylenda CA: Agency for Toxic Substances and Disease Registry’s 1997 priority list of hazardous substances. Latent effects–carcinogenesis, neurotoxicology, and developmental deficits in humans and animals. Toxicol Ind Health. 1999, 15 (7): 602-644.PubMed Ostrowski SR, Wilbur S, Chou CH, Pohl HR, Stevens YW, Allred PM, Roney N, Fay M, Tylenda CA: Agency for Toxic Substances and Disease Registry’s 1997 priority list of hazardous substances. Latent effects–carcinogenesis, neurotoxicology, and developmental deficits in humans and animals. Toxicol Ind Health. 1999, 15 (7): 602-644.PubMed
17.
go back to reference IARC: Overall evaluations of carcinogenicity—an updating of IARC monographs volumes 1 to 42. International Agency for Research on Cancer, Monographs on the Evaluation of Carcinogenic Risks to Humans. 987, Lyon, France: IARCPress, Suppl. 7 IARC: Overall evaluations of carcinogenicity—an updating of IARC monographs volumes 1 to 42. International Agency for Research on Cancer, Monographs on the Evaluation of Carcinogenic Risks to Humans. 987, Lyon, France: IARCPress, Suppl. 7
18.
go back to reference Heller JG, Thornhill PG, Conard BR: New views on the hypothesis of respiratory cancer risk from soluble nickel exposure; and reconsideration of this risk’s historical sources in nickel refineries. J Occup Med Toxicol. 2009, 4: 23-10.1186/1745-6673-4-23.CrossRefPubMedPubMedCentral Heller JG, Thornhill PG, Conard BR: New views on the hypothesis of respiratory cancer risk from soluble nickel exposure; and reconsideration of this risk’s historical sources in nickel refineries. J Occup Med Toxicol. 2009, 4: 23-10.1186/1745-6673-4-23.CrossRefPubMedPubMedCentral
19.
go back to reference Grimsrud TK, Berge SR, Haldorsen T, Andersen A: Can lung cancer risk among nickel refinery workers be explained by occupational exposures other than nickel?. Epidemiology. 2005, 16: 146-154. 10.1097/01.ede.0000152902.48916.d7.CrossRefPubMed Grimsrud TK, Berge SR, Haldorsen T, Andersen A: Can lung cancer risk among nickel refinery workers be explained by occupational exposures other than nickel?. Epidemiology. 2005, 16: 146-154. 10.1097/01.ede.0000152902.48916.d7.CrossRefPubMed
20.
go back to reference Lamm SH, Engel A, Penn CA, Chen R, Feinleib M: Arsenic cancer risk confounder in southwest Taiwan data set. Environ Health Perspect. 2006, 114: 1077-1082. 10.1289/ehp.8704.CrossRefPubMedPubMedCentral Lamm SH, Engel A, Penn CA, Chen R, Feinleib M: Arsenic cancer risk confounder in southwest Taiwan data set. Environ Health Perspect. 2006, 114: 1077-1082. 10.1289/ehp.8704.CrossRefPubMedPubMedCentral
21.
go back to reference Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC: Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control. 2003, 14: 303-310. 10.1023/A:1023905900171.CrossRefPubMed Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC: Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control. 2003, 14: 303-310. 10.1023/A:1023905900171.CrossRefPubMed
22.
go back to reference Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Chao SC, Lee JY, Christiani DC: Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med. 2003, 45: 241-248. 10.1097/01.jom.0000058336.05741.e8.CrossRefPubMed Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Chao SC, Lee JY, Christiani DC: Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med. 2003, 45: 241-248. 10.1097/01.jom.0000058336.05741.e8.CrossRefPubMed
23.
go back to reference Chen CL, Hsu LI, Chiou HY, Hsueh YM, Chen SY, Wu MM, Chen CJ, Blackfoot Disease Study Group: Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA. 2004, 292: 2984-2990. 10.1001/jama.292.24.2984.CrossRefPubMed Chen CL, Hsu LI, Chiou HY, Hsueh YM, Chen SY, Wu MM, Chen CJ, Blackfoot Disease Study Group: Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA. 2004, 292: 2984-2990. 10.1001/jama.292.24.2984.CrossRefPubMed
24.
go back to reference Steinmaus C, Bates MN, Yuan Y, Kalman D, Atallah R, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Hoang BK, Smith AH: Arsenic methylation and bladder cancer risk in case–control studies in Argentina and the United States. J Occup Environ Med. 2006, 48: 478-488. 10.1097/01.jom.0000200982.28276.70.CrossRefPubMed Steinmaus C, Bates MN, Yuan Y, Kalman D, Atallah R, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Hoang BK, Smith AH: Arsenic methylation and bladder cancer risk in case–control studies in Argentina and the United States. J Occup Environ Med. 2006, 48: 478-488. 10.1097/01.jom.0000200982.28276.70.CrossRefPubMed
25.
go back to reference Smith AH, Ercumen A, Yuan Y, Steinmaus CM: Increased lung cancer risks are similar whether arsenic is ingested or inhaled. J Expo Sci Environ Epidemiol. 2009, 19 (4): 343-348. 10.1038/jes.2008.73.CrossRefPubMedPubMedCentral Smith AH, Ercumen A, Yuan Y, Steinmaus CM: Increased lung cancer risks are similar whether arsenic is ingested or inhaled. J Expo Sci Environ Epidemiol. 2009, 19 (4): 343-348. 10.1038/jes.2008.73.CrossRefPubMedPubMedCentral
26.
go back to reference Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A: Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control. 2004, 15: 465-472.CrossRefPubMed Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A: Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control. 2004, 15: 465-472.CrossRefPubMed
27.
go back to reference Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, Greenberg ER: Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case–control study. Am J Epidemiol. 2001, 153 (6): 559-565. 10.1093/aje/153.6.559.CrossRefPubMed Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, Greenberg ER: Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case–control study. Am J Epidemiol. 2001, 153 (6): 559-565. 10.1093/aje/153.6.559.CrossRefPubMed
28.
go back to reference Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ: Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect. 2009, 117 (11): 1718-1723.PubMedPubMedCentral Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ: Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect. 2009, 117 (11): 1718-1723.PubMedPubMedCentral
29.
go back to reference Nieder AM, MacKinnon JA, Fleming LE, Kearney G, Hu JJ, Sherman RL, Huang Y, Lee DJ: Bladder cancer clusters in Florida: identifying populations at risk. J Urol. 2009, 182: 46-50. 10.1016/j.juro.2009.02.149. discussion 51CrossRefPubMed Nieder AM, MacKinnon JA, Fleming LE, Kearney G, Hu JJ, Sherman RL, Huang Y, Lee DJ: Bladder cancer clusters in Florida: identifying populations at risk. J Urol. 2009, 182: 46-50. 10.1016/j.juro.2009.02.149. discussion 51CrossRefPubMed
30.
go back to reference Ojajärvi IA, Partanen TJ, Ahlbom A, Boffetta P, Hakulinen T, Jourenkova N, Kauppinen TP, Kogevinas M, Porta M, Vainio HU, Weiderpass E, Wesseling CH: Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med. 2000, 57: 316-324. 10.1136/oem.57.5.316.CrossRefPubMedPubMedCentral Ojajärvi IA, Partanen TJ, Ahlbom A, Boffetta P, Hakulinen T, Jourenkova N, Kauppinen TP, Kogevinas M, Porta M, Vainio HU, Weiderpass E, Wesseling CH: Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med. 2000, 57: 316-324. 10.1136/oem.57.5.316.CrossRefPubMedPubMedCentral
31.
go back to reference Kuldorff M: A spatial scan statistic. Communication in Statistics Theory and Methods. 1997, 26: 1481-1496. 10.1080/03610929708831995.CrossRef Kuldorff M: A spatial scan statistic. Communication in Statistics Theory and Methods. 1997, 26: 1481-1496. 10.1080/03610929708831995.CrossRef
33.
go back to reference Sheehan TJ, Gershman ST, MacDougall LA, Danley RA, Mroszczyk M, Sorensen AM, Kulldorff M: Geographic assessment of breast cancer screening in towns zip codes and census tracts. J Pub Health Manag Prac. 2000, 6: 48-57.CrossRef Sheehan TJ, Gershman ST, MacDougall LA, Danley RA, Mroszczyk M, Sorensen AM, Kulldorff M: Geographic assessment of breast cancer screening in towns zip codes and census tracts. J Pub Health Manag Prac. 2000, 6: 48-57.CrossRef
34.
go back to reference Sheehan TJ, DeChello LM, Kulldorff M, Gregorio DI, Gershman S, Mroszczyk M: The geographic distribution of cancer incidence in Massachusetts 1988 to 1997, adjusted for covariates. Int J Health Geogr. 2004, 3: 17-10.1186/1476-072X-3-17.CrossRef Sheehan TJ, DeChello LM, Kulldorff M, Gregorio DI, Gershman S, Mroszczyk M: The geographic distribution of cancer incidence in Massachusetts 1988 to 1997, adjusted for covariates. Int J Health Geogr. 2004, 3: 17-10.1186/1476-072X-3-17.CrossRef
35.
go back to reference Klein CB, Leszczynska J, Hickey C, Rossman TG: Further evidence against a direct genotoxic mode of action for arsenic-induced cancer. Toxicol Appl Pharmacol. 2007, 222: 289-297. 10.1016/j.taap.2006.12.033.CrossRefPubMedPubMedCentral Klein CB, Leszczynska J, Hickey C, Rossman TG: Further evidence against a direct genotoxic mode of action for arsenic-induced cancer. Toxicol Appl Pharmacol. 2007, 222: 289-297. 10.1016/j.taap.2006.12.033.CrossRefPubMedPubMedCentral
36.
go back to reference Andrew AS, Karagas MR, Hamilton JW: Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int J Cancer. 2003, 104: 263-268. 10.1002/ijc.10968.CrossRefPubMed Andrew AS, Karagas MR, Hamilton JW: Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int J Cancer. 2003, 104: 263-268. 10.1002/ijc.10968.CrossRefPubMed
37.
go back to reference Rossman TG: Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res. 2003, 533: 37-65. 10.1016/j.mrfmmm.2003.07.009.CrossRefPubMed Rossman TG: Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res. 2003, 533: 37-65. 10.1016/j.mrfmmm.2003.07.009.CrossRefPubMed
38.
go back to reference Andrew AS, Mason RA, Kelsey KT, Schned AR, Marsit CJ, Nelson HH, Karagas MR: DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicol Lett. 2009, 187: 10-14. 10.1016/j.toxlet.2009.01.013.CrossRefPubMedPubMedCentral Andrew AS, Mason RA, Kelsey KT, Schned AR, Marsit CJ, Nelson HH, Karagas MR: DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicol Lett. 2009, 187: 10-14. 10.1016/j.toxlet.2009.01.013.CrossRefPubMedPubMedCentral
39.
go back to reference Applebaum KM, Karagas MR, Hunter DJ, Catalano PJ, Byler SH, Morris S, Nelson HH: Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Environ Health Perspect. 2007, 115: 1231-1236. 10.1289/ehp.10096.CrossRefPubMedPubMedCentral Applebaum KM, Karagas MR, Hunter DJ, Catalano PJ, Byler SH, Morris S, Nelson HH: Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Environ Health Perspect. 2007, 115: 1231-1236. 10.1289/ehp.10096.CrossRefPubMedPubMedCentral
40.
go back to reference Thirumaran RK, Bermejo JL, Rudnai P, Gurzau E, Koppova K, Goessler W, Vahter M, Leonardi GS, Clemens F, Fletcher T, Hemminki K, Kumar R: Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis. 2006, 27: 1676-1681.CrossRefPubMed Thirumaran RK, Bermejo JL, Rudnai P, Gurzau E, Koppova K, Goessler W, Vahter M, Leonardi GS, Clemens F, Fletcher T, Hemminki K, Kumar R: Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis. 2006, 27: 1676-1681.CrossRefPubMed
41.
go back to reference Sax SN, Bennett DH, Chillrud SN, Ross J, Kinney PL, Spengler JD: A cancer risk assessment of inner-city teenagers living in New York City and Los Angeles. Environ Health Perspect. 2006, 114: 1558-1566. 10.1289/ehp.8507.CrossRefPubMedPubMedCentral Sax SN, Bennett DH, Chillrud SN, Ross J, Kinney PL, Spengler JD: A cancer risk assessment of inner-city teenagers living in New York City and Los Angeles. Environ Health Perspect. 2006, 114: 1558-1566. 10.1289/ehp.8507.CrossRefPubMedPubMedCentral
Metadata
Title
Pancreatic cancer clusters and arsenic-contaminated drinking water wells in Florida
Authors
Wen Liu-Mares
Jill A MacKinnon
Recinda Sherman
Lora E Fleming
Caio Rocha-Lima
Jennifer J Hu
David J Lee
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-111

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine